Toronto Dominion Bank’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-194
Closed -$1K 1761
2022
Q2
$1K Buy
+194
New +$843 ﹤0.01% 1268
2022
Q1
Sell
-177,221
Closed -$1.31M 2137
2021
Q4
$1.31M Buy
177,221
+175,883
+13,145% +$1.09M ﹤0.01% 956
2021
Q3
$8K Sell
1,338
-7,237
-84% -$41.8K ﹤0.01% 1291
2021
Q2
$57K Buy
+8,575
New +$59.8K ﹤0.01% 1194

Other funds holding IMGN

Toronto Dominion Bank's IMGN Position: Q3 2022 in Review

Toronto Dominion Bank sold out of Immunogen Inc (IMGN) in Q3 2022, closing a stake of 194 shares — an estimated $1K sold.

Toronto Dominion Bank first reported a position in IMGN in Q2 2021 and held it in 4 quarters. The position peaked at $1.31M in Q4 2021. 222 funds tracked by Wall St. Rank hold IMGN as of Q3 2022.

  • Toronto Dominion Bank reported no remaining Immunogen Inc position as of Q3 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 194 Immunogen Inc shares in Q3 2022, an estimated $1K.
  • Toronto Dominion Bank first reported a position in Immunogen Inc in Q2 2021 and held it in 4 quarters.
  • Toronto Dominion Bank's Immunogen Inc position peaked at $1.31M in Q4 2021.
  • 222 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2022.

Based on Toronto Dominion Bank's 13F filing for Q3 2022, filed 9 Nov 2022.